Charles River Laboratories International Inc CRL:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:39 AM EDT
439.01quote price arrow up+8.94 (+2.08%)
Volume
31,321
52 week range
219.79 - 460.21
Loading...
  • Open433.16
  • Day High439.37
  • Day Low430.89
  • Prev Close430.07
  • 52 Week High460.21
  • 52 Week High Date09/24/21
  • 52 Week Low219.79
  • 52 Week Low Date10/29/20

Key Stats

  • Market Cap22.126B
  • Shares Out50.40M
  • 10 Day Average Volume0.27M
  • Dividend-
  • Dividend Yield-
  • Beta1.13
  • YTD % Change75.29

KEY STATS

  • Open433.16
  • Day High439.37
  • Day Low430.89
  • Prev Close430.07
  • 52 Week High460.21
  • 52 Week High Date09/24/21
  • 52 Week Low219.79
  • 52 Week Low Date10/29/20
  • Market Cap22.126B
  • Shares Out50.40M
  • 10 Day Average Volume0.27M
  • Dividend-
  • Dividend Yield-
  • Beta1.13
  • YTD % Change75.29

RATIOS/PROFITABILITY

  • EPS (TTM)7.75
  • P/E (TTM)56.67
  • Fwd P/E (NTM)40.61
  • EBITDA (TTM)789.845M
  • ROE (TTM)19.46%
  • Revenue (TTM)3.273B
  • Gross Margin (TTM)37.87%
  • Net Margin (TTM)12.24%
  • Debt To Equity (MRQ)117.76%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Charles River Laboratories International Inc

Profile

MORE
Charles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company is engaged in the business of providing the research models required in research and development of new drugs, devices, and therapies. The Company operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment includes the Research Models, Research Model...
James Foster J.D.
Chairman
David Smith
Chief Financial Officer
Joseph LaPlume
Executive Vice President
William Barbo
Executive Vice President
Birgit Girshick
Executive Vice President
Address
251 Ballardvale St
Wilmington, MA
01887-1096
United States

Top Peers

SYMBOLLASTCHG%CHG
INCY
Incyte Corp
65.45+0.48+0.74%
EXAS
Exact Sciences Corp
96.96+2.79+2.96%
NVZMY
Novozymes A/S
76.41+2.92+3.97%
ALNY
Alnylam Pharmaceuticals Inc
160.65-30.50-15.96%
SYNH
Syneos Health Inc
89.77+1.74+1.98%